Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials

Citation:

Ferreira JP, Marques P, Anker SD, et al. Diabetes Obes Metab. 2026 Feb;28(2):1105-1115. Epub 2025 Nov 10. PMID: 41208574; PMCID: PMC12803639.